Idiopathic Pulmonary Fibrosis (IPF) – weathering the pandemic
Top line data on the ATTRACT study
Interview with Ella Radvogin, Clinical Psychologist at Alex Therapeutics
Idiopathic Pulmonary Fibrosis: 5 Things to Know
Vicore’s ATTRACT study shows promise for novel drug C21 against COVID-19 in hospitalised patients